ArticleEuropean journal of gastroenterology & hepatology2021
Prediction factors of tolvaptan effectiveness in patients with refractory ascites complicated with hepatocellular carcinoma.
Michitaka Imai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it